Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00067405 · ClinicalTrials.gov registry record · Phase 1

Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia

A Phase 1 study of Fibromyalgia, sponsored by National Center for Complementary and Integrative Health (NCCIH).

Completed
Registry status
Phase 1
Development phase
40
Enrollment target
1
Study location

NCT00067405 is a Phase 1 study of Fibromyalgia that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 40 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00067405, a Phase 1 study of Fibromyalgia, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).

COMPLETED
Registry status
Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if intravenous micronutrient therapy (IVMT) is effective in the treatment of fibromyalgia, as assessed by validated functional and pain measures.

Conditions Studied

Interventions

  • DRUG Intravenous micronutrient therapy

Study Locations (1)

Connecticut

  • Yale-Griffin Prevention Research Center - Derby

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2004-06
Est. Completion 2007-07
Phase Phase 1

What the Registry Record Tells You About NCT00067405

The ClinicalTrials.gov registry entry for NCT00067405 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (78% lower). The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Intravenous micronutrient therapy is the first listed.

NCT00067405 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT00067405 about?

NCT00067405 is a clinical study titled "Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia". The purpose of this study is to determine if intravenous micronutrient therapy (IVMT) is effective in the treatment of fibromyalgia, as assessed by validated functional and pain measures.

What is the current status of trial NCT00067405?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2004-06. Estimated completion is 2007-07.

What conditions does trial NCT00067405 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT00067405?

The interventions under investigation include: Intravenous micronutrient therapy (DRUG).

Who is sponsoring clinical trial NCT00067405?

This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00067405 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.